Q2 2019 13F Holders as of 6/30/2019
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Number of holders
-
76
-
Total 13F shares, excl. options
-
44.9M
-
Shares change
-
+4.34M
-
Total reported value, excl. options
-
$535M
-
Value change
-
+$51.5M
-
Put/Call ratio
-
726.5
-
Number of buys
-
32
-
Number of sells
-
-34
-
Price
-
$11.92
Significant Holders of GLYCOMIMETICS INC - Common Stock, par value $0.001 per share (GLYC) as of Q2 2019
86 filings reported holding GLYC - GLYCOMIMETICS INC - Common Stock, par value $0.001 per share as of Q2 2019.
GLYCOMIMETICS INC - Common Stock, par value $0.001 per share (GLYC) has 76 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 44.9M shares
.
Largest 10 shareholders include NEA Management Company, LLC (9.09M shares), Invesco Ltd. (4.77M shares), WELLINGTON MANAGEMENT GROUP LLP (4.76M shares), FMR LLC (4.21M shares), PRICE T ROWE ASSOCIATES INC /MD/ (3.04M shares), BlackRock Inc. (2.86M shares), Redmile Group, LLC (2.01M shares), VANGUARD GROUP INC (1.74M shares), FRANKLIN RESOURCES INC (1.72M shares), and JENNISON ASSOCIATES LLC (1.42M shares).
This table shows the top 76 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.